Microbial translocation: A marker of advanced HIV-1 infection and a predictor of treatment failure?

Journal of Infectious Diseases

Volumn 203, Issue 5, 2011, Pages 747-748

  Cassol, Edana ^a   Rossouw, Theresa ^d   Seebregts, Chris ^e   Cassol, Sharon ^b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e eHealth Research and Innovation Platform   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BACTERIAL DNA; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CD16 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VIRUS RNA;

BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DISEASE COURSE; DRUG TREATMENT FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; MACROPHAGE ACTIVATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS ACTIVATION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION;

AFRICA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL TRANSLOCATION; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HUMANS; LIPOPOLYSACCHARIDES; TREATMENT FAILURE; VIRAL LOAD;

EID: 79751498592     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq109     Document Type: Letter

References (12)

1. Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A 2009; 106:6718-23.
2. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-85.
3. Ciccone RJ, Read SW, Mannon PJ, et al. Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol 2010; 3:172-81.
4. Ancuta P, Kamat A, Kunstman K, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008; 396:e2516.
5. Balagobal A, Philp FH, Astemborski J, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterol 2008; 135:226-33. (Pubitemid 351899010)
6. Lawn S, Labeta MO, Arias M, et al. Elevated serum concentrations of soluble CD14 in HIV- and HIV-1+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin Exp Immunol 2000; 120:483-7. (Pubitemid 30365554)
7. Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206:1883-97.
8. Cassol E, Malfeld S, Mahasha P, et al. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J infect Dis 2010; 202:723-33.
9. Remple H, Sun B, Calosing C, et al. Interferon-a drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS 2010; 24:1415-23.
10. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13:85-94. (Pubitemid 32222977)
11. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005; 11:doi:10.1179/096805105X 46565.
12. Lester RT, Yao X-D, Ball B, et al. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008; 22:685-94. (Pubitemid 351450636)